AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Early in pregnancy: blood levels of two molecules may predict preeclampsia.(Obstetrics)

OB GYN News

| March 15, 2004 | Worcester, Sharon | COPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

NEW ORLEANS -- Increased blood levels of soluble fms-like tyrosine kinase 1 during pregnancy and low levels of placental growth factor early in pregnancy each appear to predict development of preeclampsia, Dr. Richard Levine reported at the annual meeting of the Society for Maternal-Fetal Medicine.

The findings are a "promising lead in the pursuit of a life-threatening disorder that has defied all attempts to prevent or cure it," Dr. Duane Alexander, director of the National Institute of Child Health and Human Development (NICHD) in Bethesda, Md., said in a statement.

In a nested case-control study of 120 pairs of blood samples--1 each from a pregnant woman who developed preeclampsia and a normotensive control matched for gestational age--levels of soluble fms-like tyrosine kinase 1 (sFlt-1) were three times higher in the preeclampsia group by the time of disease onset than in controls. Levels were similar at the start of pregnancy, but slight increases were noted in the preeclampsia group beginning about 11 weeks before disease onset. The largest increases were seen 5 weeks before disease onset, said Dr. Levine of the NICHD, which sponsored the study.

Placental growth factor (PlGF) was ...

Related articles from newspapers, magazines, journals, and more
ThromboGenics and Geymonat Announce Collaboration for Development of PlGF...
Press release article from: PR Newswire March 3, 2004 700+ words
...collaborative agreement for co-development of PlGF (Placental Growth Factor), a drug candidate...rights to the therapeutic applications of PlGF, and Geymonat's exclusive rights to...which characterizes the protein sequence of PlGF. Breakthrough research on PlGF has been...
ThromboGenics and Geymonat Announce Collaboration for Development of PlGF...
Press release article from: PR Newswire March 3, 2004 700+ words
...collaborative agreement for co-development of PlGF (Placental Growth Factor), a drug candidate...rights to the therapeutic applications of PlGF, and Geymonat's exclusive rights to...which characterizes the protein sequence of PlGF. Breakthrough research on PlGF has been...
Urinary PlGF predicts early-onset preeclampsia.(Women's Health)
Magazine article from: Family Practice News Tucker, Miriam E. March 15, 2005 700+ words
...Karumanchi, M.D., reported. "Low urinary PLGF antedates the clinical diagnosis of preeclampsia...77-85). In all the women, urinary PlGF levels increased during the first two trimesters...SGA) infant. Alterations in urinary PlGF levels at 21-32 weeks were also more...
Urinary PlGF predicts early-onset preeclampsia.(Obstetrics)
Magazine article from: OB GYN News Tucker, Miriam E. February 1, 2005 700+ words
...77-85). In all the women, urinary PlGF levels increased during the first two trimesters...women were divided by quartiles of urinary PlGF obtained at 21-32 weeks' gestation and...into urine, the current study focused on PlGF, which binds to sFlt-1, as a more clinically...
Dade Behring Grants Sublicense to Abbott for the Use of Placental Growth Factor...
Press release article from: Business Wire January 10, 2006 700+ words
...cardiac marker placental growth factor (PlGF), for further development of tests for...diseases. Studies show that levels of PlGF may be useful in the prognosis of acute...to make emerging cardiac markers such as PlGF available to health care providers throughout...
ThromboGenics and BioInvent Report Positive Phase I Results for Anti-PlGF...
Press release article from: PR Newswire June 3, 2008 700+ words
...antibody that targets the angiogenic factor PlGF (placental growth factor). The product has demonstrated inhibition of PlGF-associated angiogenesis and tumour...promoting the formation of blood vessels. PlGF is a homologue of VEGF but, unlike VEGF...
ThromboGenics and BioInvent Complete Phase I Patient Trial of Anti-PlGF Cancer...
Press release article from: PR Newswire November 16, 2009 700+ words
...BioInvent International; these include TB-402 (Anti-Factor VIII), a long acting anti-coagulant, and TB-403 (anti-PlGF) for cancer. ThromboGenics has built strong links with the University of Leuven and the Flanders Institute for Biotechnology...
Paroxetine retards disease onset in huntingtin mutant mice.
Newspaper article from: Biotech Week June 9, 2004 700+ words
...NewsRx.com & NewsRx.net) -- Paroxetine retards disease onset and progression in huntingtin mutant mice. "We report that...their study in the Annals of Neurology (Paroxetine retards disease onset and progression in huntingtin mutant mice. Ann Neurol...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA